Dr Richard A Kondan, DO | |
599 W State St, Ste 203, Doylestown, PA 18901 | |
(215) 348-9711 | |
(215) 348-9784 |
Full Name | Dr Richard A Kondan |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 599 W State St, Doylestown, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215986245 | NPI | - | NPPES |
0014792030005 | Medicaid | PA | |
757336 | Other | PA | BCBS |
07000290010 | Other | PA | KEYSTONE |
1296316008 | Other | PA | CIGNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | OS007466L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Richard A Kondan, DO 599 W State St, Ste 203, Doylestown, PA 18901 Ph: (215) 348-9711 | Dr Richard A Kondan, DO 599 W State St, Ste 203, Doylestown, PA 18901 Ph: (215) 348-9711 |
News Archive
Numerous studies show that non-steroidal anti-inflammatory drugs reduce the risk of colon cancer. However, animal studies testing the NSAID naproxen or its derivative, NO-naproxen, have focused primarily on chemically-induced tumor formation.
Two daily fasting diets, also known as time-restricted feeding diets, are effective for weight loss, according to a new study published by researchers from the University of Illinois at Chicago.
Emergent BioSolutions Inc. reported total revenue for Q1 2014 of $53.9 million as compared to $43.1 million in 2013. In addition, Q1 2014 net loss was $20.2 million, or $0.55 per share, as compared to a net loss of $8.1 million, or $0.22 per share, in 2013.
Simcere Pharmaceutical Group ("Simcere" or the "Company"), a leading pharmaceutical company specializing in development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement with OSI Pharmaceuticals, Inc., to develop, manufacture, and market its KDR/Kit inhibitor OSI-930 in China.
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow that most often affects older adults. CLL responds to bone marrow stem cell transplantation (allo-HSCT); however, the rate of relapse for CLL remains relatively high.
› Verified 9 days ago
Andrew E Krick, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 Farm Lane, Doylestown, PA 18901 Phone: 215-348-3990 Fax: 215-348-7705 | |
Sherilyn Lisa Tittermary Mccollum, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1456 Ferry Road, Suite 403, Doylestown, PA 18901 Phone: 267-483-8094 Fax: 267-483-8312 | |
Dr. George Wiemann, M.D, FACC Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 W State St, Doylestown, PA 18901 Phone: 215-345-1900 Fax: 215-345-4579 | |
Marvin Ralph Gordon, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4740 Dickinson Way, Doylestown, PA 18902 Phone: 215-794-2528 Fax: 267-544-0105 | |
Christopher P Hermann, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301s Main St, Ste 2w, Doylestown, PA 18901 Phone: 215-348-4800 Fax: 215-348-4350 | |
Mr. Les A Szekely, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2003 Lower State Rd Unit 110, Doylestown, PA 18901 Phone: 215-348-1310 Fax: 215-348-8615 | |
Venu Pasricha, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 595 W State St, Doylestown, PA 18901 Phone: 215-345-2885 Fax: 215-345-2552 |